HIV-1/hepatitis B coinfection. - Wikidata - awgldk - TriplyDB

HIV-1/hepatitis B coinfection.

HIV-1/hepatitis B coinfection.

http://www.wikidata.org/entity/Q36140666

about

HIV-1/hepatitis B coinfection.

http://www.wikidata.org/entity/Q36140666

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

HIV-1/hepatitis B coinfection.

@ast

HIV-1/hepatitis B coinfection.

@en

type

label

HIV-1/hepatitis B coinfection.

@ast

HIV-1/hepatitis B coinfection.

@en

prefLabel

HIV-1/hepatitis B coinfection.

@ast

HIV-1/hepatitis B coinfection.

@en

P1433

Q36140666-12582E71-4F69-46FB-A299-E51CF6D53B5B

P1476

Q36140666-96565E23-2B7E-4E67-B085-26BBE4DC894F

P2093

Q36140666-4C10B095-C2C2-4DD6-8F70-DBFFDD3E7657

P2860

Q36140666-077EA533-EE76-4DFE-BFB9-083FF50AA7E7

Q36140666-1D4174CE-6F7F-4A85-9388-9CE4822F5A4B

Q36140666-2985A14E-8928-4C4E-9511-ACCB63C434CE

Q36140666-2CD2327C-7B7B-48C3-8129-19EAEFDDF7A0

Q36140666-53BED9F2-F5CB-4A01-B504-F421FBBC4FF0

Q36140666-64FBA9B6-64B4-40AD-8E87-3E22DB2CDC8B

Q36140666-6CFE06E1-BA41-41D7-BEC9-E7CE91F0E781

Q36140666-6F7B73D8-6187-405B-BE65-BEDC63E3D874

Q36140666-7D33D1F6-0275-497F-AFDF-EF16EB7719E1

Q36140666-848B35A5-0EEB-4228-B4E8-BC6ADD5BD501

P304

Q36140666-DA54DF94-47CE-407E-964F-BC6082197725

P31

Q36140666-94FD16CD-4F9D-4BCB-BF3A-DF1E69170D5E

P356

Q36140666-A80960D9-2C1B-4651-B4E3-9AE5F8004C7B

P433

Q36140666-E059DE7F-AB0C-4ABF-83D8-1F9CB487AED3

P478

Q36140666-1190EE96-C2FD-48E2-8DEE-0EBDCB6263D2

P577

Q36140666-7CB868C5-9581-49DE-B84C-9F8DE9D07D6C

P698

Q36140666-8C6BA285-6556-40AF-9F8C-FC26DCCFCF37

P356

14787210.3.2.229

P1433

Expert Review of Anti-infective Therapy

P1476

HIV-1/hepatitis B coinfection.

@en

P2093

Yves Benhamou

http://www.w3.org/2001/XMLSchema#string

P2860

Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B

Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients

Dose range study of pharmacokinetics, safety, and preliminary antiviral activity of emtricitabine in adults with hepatitis B virus infection.

Risk factors for severe hepatic injury after introduction of highly active antiretroviral therapy.

Nucleoside analogues for chronic hepatitis B: antiviral efficacy and viral resistance.

Interactions of the human immunodeficiency virus and the hepatotropic viruses.

A treatment algorithm for the management of chronic hepatitis B virus infection in the United States.

Treatment of chronic hepatitis B in the human immunodeficiency virus-infected patient: present and future.

Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids.

Inhibition of the replication of the DNA polymerase M550V mutation variant of human hepatitis B virus by adefovir, tenofovir, L-FMAU, DAPD, penciclovir and lobucavir.

P304

229-239

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14787210.3.2.229

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2005-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15918780

http://www.w3.org/2001/XMLSchema#string